中国临床药学杂志

参考文献

[1]刘松年,荆凌华,李兰英.华法林预防老年非瓣膜病慢性心房颤动患者缺血性脑卒中的临床研究[J].国外医学:内科学分册,2006,33(5):229.

[2]Nutescu E,Chuatrisorn I,Hellenbart E.Drug and dietary interactions of warfarin and novel oral anticoagulants:an update[J].J Thromb Thrombolysis,2011,31(3):326.

[3]Ansell JE,Hughes R.Evolving models of warfarin management:anticoagulation clinics,patient self-monitoring,and patient self-management[J].Am Heart J,1996,132(5):1095.

[4]Baglin TP.Guidelines on oral anticoagulation(warfarin):third edition 2005 update[J].Br J Haematol,2006,132(3):267.

[5]Testa S,Alatri A,Paoletti O,et al.Reorganization of an anticoagulation clinic using a telemedicine system:description of the model and preliminary results[J].Intern Emerg Med,2006,1(1):24.

[6]Boddy C.Pharmacist involvement with warfarin dosing for in-patients[J].Pham World Sci,2001,23(1):31.

[7]BOUNDA Guy-Armel,郝智慧,葛卫红,等.世界各地抗凝门诊简介及其对中国内地抗凝管理的启示[J].中国临床药学杂志,2010,19(4):261.

[8]Stephen E,Andrea B,George L,et al.Randomized trial of lotterybased incentives to improve warfarin adherence[J].Am Heart J,2012,164(2):268.

[9]Ryan F,Byrne S,O’Shea S.Managing oral anticoagulation therapy:improving clinical outcomes,A review[J].J Clin Pharm Ther,2008,33(6):581.

[10]Hosmane SR,Tucker J,Osman D,et al.Inpatient oral anticoagulation management by clincial pharmacists:safety and cost effectiveness[J].J Clin Med Res,2010,2(2):90.

[11]Tammy JB,Leslie G,Stephen LA,et al.Evaluation of a pharmacist-managed anticoagulation clinic:improving patient care[J].Open Med,2009,3(1):16.

[12]葛卫红,方芸,王东进,等.华法林抗凝治疗临床药师指导手册[M].北京:人民卫生出版社,2009:91.

[13]Hurlen M,Abdelnoor M,Smith P,et a1.Warfarin,aspirin,or both after myocardial infarction[J].N Engl J Med,2002,347(6):969.

[14]钟伟,周舍典,彭俊,等.影响华法林疗效诸因素的综合分析[J].中国现代药物应用,2010,4(6):29.